NCT03693430 - Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity | Biotech Hunter

Enrollment

304

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

January 29, 2021

Study Completion Date

March 23, 2021

Conditions

OverweightObesity

Interventions

DRUG

Semaglutide

Subcutaneous (s.c., under the skin) injections of semaglutide once weekly at escalating doses (0.25 mg/week, 0.5 mg/week, 1.0 mg/week, 1.7 mg/week, 2.4 mg/week). The dose will be escalated to next level every 4 weeks

DRUG

Placebo (Semaglutide)

S.c. injections of placebo once weekly at a similar dose escalation manner as semaglutide (placebo matched to semaglutide 0.25 mg/week, 0.5 mg/week, 1.0 mg/week, 1.7 mg/week, 2.4 mg/week). The dose will be escalated to next level every 4 weeks

Trial Locations (41)

1132

Novo Nordisk Investigational Site, Budapest

1152

Novo Nordisk Investigational Site, Budapest

2900

Novo Nordisk Investigational Site, Komárom

4043

Novo Nordisk Investigational Site, Debrecen

7100

Novo Nordisk Investigational Site, Szekszárd

12203

Novo Nordisk Investigational Site, Albany

14609

Novo Nordisk Investigational Site, Rochester

22206

Novo Nordisk Investigational Site, Arlington

28223

Novo Nordisk Investigational Site, Pozuelo de Alarcón

28922

Novo Nordisk Investigational Site, Alcorcón

31008

Novo Nordisk Investigational Site, Pamplona

32205

Novo Nordisk Investigational Site, Jacksonville

34471

Novo Nordisk Investigational Site, Ocala

35222

Novo Nordisk Investigational Site, Birmingham

37660

Novo Nordisk Investigational Site, Kingsport

40138

Novo Nordisk Investigational Site, Bologna

41010

Novo Nordisk Investigational Site, Seville

53100

Novo Nordisk Investigational Site, Siena

56124

Novo Nordisk Investigational Site, Pisa

59701

Novo Nordisk Investigational Site, Butte

63303

Novo Nordisk Investigational Site, City of Saint Peters

78681

Novo Nordisk Investigational Site, Round Rock

78731

Novo Nordisk Investigational Site, Austin

80045

Novo Nordisk Investigational Site, Aurora

80401

Novo Nordisk Investigational Site, Golden

90057

Novo Nordisk Investigational Site, Los Angeles

90127

Novo Nordisk Investigational Site, Palermo

06708

Novo Nordisk Investigational Site, Waterbury

V3Z 2N6

Novo Nordisk Investigational Site, Surrey

E1G 1A7

Novo Nordisk Investigational Site, Moncton

B3H 1V7

Novo Nordisk Investigational Site, Halifax

L8L 5G8

Novo Nordisk Investigational Site, Hamilton

L8M 1K7

Novo Nordisk Investigational Site, Hamilton

M4G 3E8

Novo Nordisk Investigational Site, Toronto

M4P 1P2

Novo Nordisk Investigational Site, Toronto

H4N 2W2

Novo Nordisk Investigational Site, Montreal

G1V 4G2

Novo Nordisk Investigational Site, Québec

H-1134

Novo Nordisk Investigational Site, Budapest

00168

Novo Nordisk Investigational Site, Rome

04009

Novo Nordisk Investigational Site, Almería

08907

Novo Nordisk Investigational Site, L'Hospitalet de Llobregat